A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects
Author:
Affiliation:
1. Satsuma Pharmaceuticals Inc. South San Francisco CA USA
2. Seaview/Quotient Miami FL USA
Funder
Satsuma Pharmaceuticals, Inc.
Publisher
Wiley
Subject
Clinical Neurology,Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.13737
Reference25 articles.
1. DHE in the Pharmacotherapy of Migraine: Potential for a Larger Role
2. Revisiting the Role of Ergots in the Treatment of Migraine and Headache
3. Dihydroergotamine: A Review of Formulation Approaches For the Acute Treatment of Migraine
4. STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD ® ) Device, in Healthy Adult Subjects
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery;Journal of Drug Delivery Science and Technology;2024-03
2. Global Epidemiology, Clinical Features, Diagnosis and Current Therapeutic Novelties in Migraine Therapy and their Prevention: A Narrative Review;Current Pharmaceutical Design;2023-11
3. The Pharmacokinetics of Drugs Delivered to the Upper Nasal Space;Pharmaceutical Medicine;2023-08-03
4. Intranasal transmucosal drug delivery: An alternative approach to the parenteral route for medical emergencies;Journal of Drug Delivery Science and Technology;2023-05
5. Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2022-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3